Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014.
暂无分享,去创建一个
D. Saunders | M. Fukuda | Philip L. Smith | J. Patel | R. Huy | Michele D Spring | Jessica T. Lin | Jaymin C. Patel | Soklyda Chann | Nillawan Buathong | S. Chaorattanakawee | P. Gosi | Mariusz Wojnarski | C. Lon | Lauren Levitz | Shannon Takala-Harrison | Nou Samon | M. Wojnarski | Darapiseth Sea | Khengheng Thay
[1] Jonathan J. Juliano,et al. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia , 2017, Genome biology and evolution.
[2] D. Fidock,et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study , 2017, The Lancet. Infectious diseases.
[3] D. Kwiatkowski,et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. , 2017, The Lancet. Infectious diseases.
[4] Philip Smith,et al. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand , 2016, Malaria Journal.
[5] Teun Bousema,et al. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data , 2016, BMC Medicine.
[6] S. Meshnick,et al. Microscopic Plasmodium falciparum Gametocytemia and Infectivity to Mosquitoes in Cambodia. , 2016, The Journal of infectious diseases.
[7] S. Meshnick,et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. , 2015, The Lancet. Infectious diseases.
[8] S. Tyner,et al. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance , 2015, Antimicrobial Agents and Chemotherapy.
[9] Saorin Kim,et al. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment , 2015, Antimicrobial Agents and Chemotherapy.
[10] R. Maude,et al. Spatial and temporal epidemiology of clinical malaria in Cambodia 2004–2013 , 2014, Malaria Journal.
[11] D. Kwiatkowski,et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.
[12] B. Genton,et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.
[13] Andrew F. Read,et al. Enhanced Transmission of Drug-Resistant Parasites to Mosquitoes following Drug Treatment in Rodent Malaria , 2012, PloS one.
[14] S. Meshnick,et al. Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.
[15] Teun Bousema,et al. Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.
[16] S. Meshnick,et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia , 2009, Malaria Journal.
[17] D. Socheat,et al. Counterfeit and substandard antimalarial drugs in Cambodia. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[18] R. Price,et al. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.
[19] R. Price,et al. Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.